ID
11715
Beschrijving
This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS). https://clinicaltrials.gov/ct2/show/NCT00356135
Link
https://clinicaltrials.gov/ct2/show/NCT00356135
Trefwoorden
Versies (1)
- 28-07-15 28-07-15 -
Geüploaded op
28 juli 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility SWAP Acute Coronary Syndrome NCT00356135
Eligibility Criteria
- StudyEvent: ODM
Beschrijving
Exclusion Criteria
Beschrijving
Left main coronary artery stent
Datatype
boolean
Alias
- UMLS CUI-1
- N
Beschrijving
left anterior descending (LAD) bifurcation stent
Datatype
boolean
Alias
- UMLS CUI-1
- C3836455
Beschrijving
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Datatype
boolean
Alias
- UMLS CUI-1
- C1532338
Beschrijving
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Datatype
boolean
Alias
- UMLS CUI-1
- C0010055
Beschrijving
Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Datatype
boolean
Alias
- UMLS CUI-1
- C0354604
Beschrijving
Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Datatype
boolean
Alias
- UMLS CUI-1
- C1096021
Beschrijving
Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.
Datatype
boolean
Alias
- UMLS CUI-1
- C0003211
Beschrijving
history of ischemic or hemorrhagic stroke
Datatype
boolean
Alias
- UMLS CUI-1
- C0559159
Beschrijving
Intracranial neoplasm
Datatype
boolean
Alias
- UMLS CUI-1
- C1527390
Beschrijving
Arteriovenous malformation
Datatype
boolean
Alias
- UMLS CUI-1
- C0003857
Beschrijving
Aneurysm
Datatype
boolean
Alias
- UMLS CUI-1
- C0002940
Beschrijving
History of transient ischemic attack (TIA)
Datatype
boolean
Alias
- UMLS CUI-1
- C0455536
Beschrijving
Have a body weight less than 60 kilograms (kg)
Datatype
boolean
Similar models
Eligibility Criteria
- StudyEvent: ODM